Literature DB >> 26889694

The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.

Andrew Preston1.   

Abstract

Whooping cough, or pertussis, caused by Bordetella pertussis is considered resurgent in a number of countries world-wide, despite continued high level vaccine coverage. Among a number of causes for this that have been proposed, is the emergence of B. pertussis strains expressing variants of the antigens contained in acellular pertussis vaccines; i.e. the evolution of B. pertussis toward vaccine escape. This commentary highlights the contradictory nature of evidence for this but also discusses the importance of understanding the role of B. pertussis adaptation to vaccine-mediated immune selection pressures for vaccine-mediated pertussis control strategies.

Entities:  

Keywords:  Bordetella pertussis; evolution; resurgence; vaccine

Mesh:

Substances:

Year:  2016        PMID: 26889694      PMCID: PMC4963054          DOI: 10.1080/21645515.2015.1137402

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  23 in total

Review 1.  Bordetella pertussis evolution in the (functional) genomics era.

Authors:  Thomas Belcher; Andrew Preston
Journal:  Pathog Dis       Date:  2015-08-21       Impact factor: 3.166

2.  Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4(+) T cells following clinical infection.

Authors:  Wanda G H Han; Kina Helm; Martien M C Poelen; Henny G Otten; Cécile A C M van Els
Journal:  Clin Immunol       Date:  2015-02-27       Impact factor: 3.969

3.  Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving.

Authors:  Katie L Sealey; Simon R Harris; Norman K Fry; Laurence D Hurst; Andrew R Gorringe; Julian Parkhill; Andrew Preston
Journal:  J Infect Dis       Date:  2014-12-08       Impact factor: 5.226

4.  Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.

Authors:  N Hegerle; G Dore; N Guiso
Journal:  Vaccine       Date:  2014-10-11       Impact factor: 3.641

5.  Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone.

Authors:  Michelle Shuel; Frances B Jamieson; Patrick Tang; Shirley Brown; David Farrell; Irene Martin; Jan Stoltz; Raymond S W Tsang
Journal:  Int J Infect Dis       Date:  2013-01-24       Impact factor: 3.623

6.  Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing.

Authors:  Thomas E Vaughan; Catherine B Pratt; Katie Sealey; Andrew Preston; Norman K Fry; Andrew R Gorringe
Journal:  Microbiology       Date:  2014-07-15       Impact factor: 2.777

Review 7.  Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.

Authors:  Drusilla L Burns; Bruce D Meade; Nancy E Messionnier
Journal:  J Infect Dis       Date:  2014-04-01       Impact factor: 5.226

8.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

9.  Small mutations in Bordetella pertussis are associated with selective sweeps.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Frits R Mooi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

Review 10.  Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin.

Authors:  F R Mooi; N A T Van Der Maas; H E De Melker
Journal:  Epidemiol Infect       Date:  2013-02-13       Impact factor: 4.434

View more
  6 in total

1.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

2.  A curated genome-scale metabolic model of Bordetella pertussis metabolism.

Authors:  Nick Fyson; Jerry King; Thomas Belcher; Andrew Preston; Caroline Colijn
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

3.  Comparative genomics of whole-cell pertussis vaccine strains from India.

Authors:  Shweta Alai; Vikas C Ghattargi; Manish Gautam; Krunal Patel; Shrikant P Pawar; Dhiraj P Dhotre; Umesh Shaligram; Sunil Gairola
Journal:  BMC Genomics       Date:  2020-05-07       Impact factor: 3.969

4.  Determining Factors for Pertussis Vaccination Policy: A Study in Five EU Countries.

Authors:  Anabelle Wong; Annick Opinel; Simon Jean-Baptiste Combes; Julie Toubiana; Sylvain Brisse
Journal:  Vaccines (Basel)       Date:  2020-01-26

5.  Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination.

Authors:  Samaneh Saedi; Azadeh Safarchi; Faranak Tayebzadeh Moghadam; Siamak Heidarzadeh; Vajihe Sadat Nikbin; Fereshteh Shahcheraghi
Journal:  Iran J Public Health       Date:  2021-07       Impact factor: 1.429

6.  Characterization of Bordetella pertussis Strains Isolated from India.

Authors:  Shweta Alai; Manish Gautam; Sonali Palkar; Jitendra Oswal; Sunil Gairola; Dhiraj P Dhotre
Journal:  Pathogens       Date:  2022-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.